ArticleFrontiers in immunology2024

Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis.

Naonobu Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.